Is there a role for ischemia detection after an acute myocardial infarction?

Jesus Peteiro1, Alberto Bouzas-Mosquera2

  • 1Unit of Echocardiography and Department of Cardiology, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIVER-CV, University of A Coruña, A Coruña 15004, Spain. pete@canalejo.org.

Insights

For acute coronary syndromes, stress echocardiography can guide revascularization decisions in ST-elevation myocardial infarction patients with multivessel disease, showing similar outcomes with less intervention. Ischemia detection may help stratify non-ST-elevation acute coronary syndrome patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Diagnostic Imaging

Background:

  • Coronary angiography and revascularization are standard for acute coronary syndromes.
  • Guidelines suggest complete revascularization for ST-elevation myocardial infarction with multivessel disease.
  • The role of ischemia detection in guiding revascularization is under investigation.

Discussion:

  • The CROSS-AMI study compared complete revascularization versus ischemia-guided revascularization in ST-elevation myocardial infarction patients with multivessel disease.
  • Only 30% of patients in the ischemia-guided arm required a second revascularization, with similar outcomes to the complete revascularization arm.
  • For non-ST-elevation acute coronary syndrome, studies show no outcome difference between invasive and ischemia-guided approaches, with a pending study to further clarify this.

Key Insights:

  • Ischemia detection, particularly with stress echocardiography, can reduce unnecessary revascularization in ST-elevation myocardial infarction patients with multivessel disease.
  • Outcomes are comparable between complete and ischemia-guided revascularization strategies.
  • Ischemia detection may play a crucial role in patient stratification for non-ST-elevation acute coronary syndrome.

Outlook:

  • Further research is needed to confirm the role of ischemia detection in non-ST-elevation acute coronary syndrome management.
  • Advancements in imaging technology and interventional techniques may enhance the utility of ischemia detection.
  • Personalized revascularization strategies based on ischemia assessment could become more prevalent.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
155
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
618
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
300
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
711
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
199